Emcure Pharmaceuticals (India) Market Value
| EMCURE Stock | 1,373 16.15 1.16% |
| Symbol | Emcure |
Emcure Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Emcure Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Emcure Pharmaceuticals.
| 01/02/2023 |
| 12/22/2024 |
If you would invest 0.00 in Emcure Pharmaceuticals on January 2, 2023 and sell it all today you would earn a total of 0.00 from holding Emcure Pharmaceuticals or generate 0.0% return on investment in Emcure Pharmaceuticals over 720 days. Emcure Pharmaceuticals is related to or competes with Akums Drugs, Innova Captab, Kingfa Science, Rico Auto, GACM Technologies, and COSMO FIRST. Emcure Pharmaceuticals is entity of India More
Emcure Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Emcure Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Emcure Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 11.6 | |||
| Value At Risk | (4.02) | |||
| Potential Upside | 3.6 |
Emcure Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Emcure Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Emcure Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Emcure Pharmaceuticals historical prices to predict the future Emcure Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (0.22) |
Emcure Pharmaceuticals Backtested Returns
Emcure Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0242, which denotes the company had a -0.0242% return per unit of standard deviation over the last 3 months. Emcure Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Emcure Pharmaceuticals' Mean Deviation of 1.58, coefficient of variation of (1,686), and Standard Deviation of 2.28 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.65, which means possible diversification benefits within a given portfolio. As returns on the market increase, Emcure Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Emcure Pharmaceuticals is expected to be smaller as well. At this point, Emcure Pharmaceuticals has a negative expected return of -0.0544%. Please make sure to confirm Emcure Pharmaceuticals' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Emcure Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Emcure Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between Emcure Pharmaceuticals time series from 2nd of January 2023 to 28th of December 2023 and 28th of December 2023 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Emcure Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Emcure Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Emcure Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Emcure Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Emcure Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Emcure Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Emcure Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Emcure Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Emcure Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Emcure Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Emcure Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Emcure Pharmaceuticals Lagged Returns
When evaluating Emcure Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Emcure Pharmaceuticals stock have on its future price. Emcure Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Emcure Pharmaceuticals autocorrelation shows the relationship between Emcure Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Emcure Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Emcure Stock
Emcure Pharmaceuticals financial ratios help investors to determine whether Emcure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emcure with respect to the benefits of owning Emcure Pharmaceuticals security.